The weekly litigation news digest is live. Subscribe now

IP Verse

Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii

Patent No. EP2325644 (titled "Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii") was filed by Becton Dickinson Infusion Therapy Systems on Oct 10, 2006. The application was issued on Jul 29, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BECKMAN COULTERApr 29, 2021BOULT WADE TENNANT
HERTIN UND PARTNER RECHTS UND PATENTANWALTE PARTG MBBApr 29, 2021-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2325644

BECTON DICKINSON INFUSION THERAPY SYSTEMS
Application Number
EP10016072A
Filing Date
Oct 10, 2006
Status
Granted And Under Opposition
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, EP2325644B1, Google Patents